-
1
-
-
84855854046
-
Chronic kidney disease
-
Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 379: 165-180
-
(2012)
Lancet
, vol.379
, pp. 165-180
-
-
Levey, A.S.1
Coresh, J.2
-
2
-
-
84959894121
-
FGF23 signaling impairs neutrophil recruitment and host defense during CKD
-
Rossaint J, Oehmichen J, Van Aken H et al. FGF23 signaling impairs neutrophil recruitment and host defense during CKD. J Clin Invest 2016; 126: 962-974
-
(2016)
J Clin Invest
, vol.126
, pp. 962-974
-
-
Rossaint, J.1
Oehmichen, J.2
Van Aken, H.3
-
3
-
-
80555148939
-
FGF23 induces left ventricular hypertrophy
-
Faul C, Amaral AP, Oskouei B et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011; 121: 4393-4408
-
(2011)
J Clin Invest
, vol.121
, pp. 4393-4408
-
-
Faul, C.1
Amaral, A.P.2
Oskouei, B.3
-
4
-
-
79957870135
-
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
-
Isakova T, Wahl P, Vargas GS et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011; 79: 1370-1378
-
(2011)
Kidney Int
, vol.79
, pp. 1370-1378
-
-
Isakova, T.1
Wahl, P.2
Vargas, G.S.3
-
5
-
-
76149101238
-
Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active
-
Shimada T, Urakawa I, Isakova T et al. Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active. J Clin EndocrinolMetabol 2010; 95: 578-585
-
(2010)
J Clin EndocrinolMetabol
, vol.95
, pp. 578-585
-
-
Shimada, T.1
Urakawa, I.2
Isakova, T.3
-
6
-
-
84884522131
-
Fibroblast growth factor-23: What we know, what we don't know, and what we need to know
-
Kovesdy CP, Quarles LD. Fibroblast growth factor-23: what we know, what we don't know, and what we need to know. Nephrol Dial Transplant 2013; 28: 2228-2236
-
(2013)
Nephrol Dial Transplant
, vol.28
, pp. 2228-2236
-
-
Kovesdy, C.P.1
Quarles, L.D.2
-
7
-
-
84969988387
-
The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy
-
Grabner A, Faul C. The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy. Curr Opin Nephrol Hypertens 2016; 25: 314-324
-
(2016)
Curr Opin Nephrol Hypertens
, vol.25
, pp. 314-324
-
-
Grabner, A.1
Faul, C.2
-
9
-
-
0141844575
-
Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX
-
Liu S, Guo R, Simpson LG et al. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 2003; 278: 37419-37426
-
(2003)
J Biol Chem
, vol.278
, pp. 37419-37426
-
-
Liu, S.1
Guo, R.2
Simpson, L.G.3
-
11
-
-
34547267177
-
Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease
-
Stubbs J, Liu S, Quarles LD. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Semin Dial 2007; 20: 302-308
-
(2007)
Semin Dial
, vol.20
, pp. 302-308
-
-
Stubbs, J.1
Liu, S.2
Quarles, L.D.3
-
12
-
-
0034703619
-
Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain
-
Yamashita T, YoshiokaM, Itoh N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 2000; 277: 494-498
-
(2000)
Biochem Biophys Res Commun
, vol.277
, pp. 494-498
-
-
Yamashita, T.1
Yoshioka, M.2
Itoh, N.3
-
13
-
-
33745828096
-
Polypeptide galnac-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation
-
Kato K, Jeanneau C, TarpMA et al. Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J BiolChem2006; 281: 18370-18377
-
(2006)
J BiolChem
, vol.281
, pp. 18370-18377
-
-
Kato, K.1
Jeanneau, C.2
Tarp, M.A.3
-
14
-
-
18444375871
-
Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo
-
Shimada T, Muto T, Urakawa I et al. Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 2002; 143: 3179-3182
-
(2002)
Endocrinology
, vol.143
, pp. 3179-3182
-
-
Shimada, T.1
Muto, T.2
Urakawa, I.3
-
15
-
-
84856720641
-
Regulation and function of the FGF23/klotho endocrine pathways
-
Martin A, David V, Quarles LD. Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev 2012; 92: 131-155
-
(2012)
Physiol Rev
, vol.92
, pp. 131-155
-
-
Martin, A.1
David, V.2
Quarles, L.D.3
-
16
-
-
1642416884
-
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and Vitamin D metabolism
-
Shimada T, Kakitani M, Yamazaki Y et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 2004; 113: 561-568
-
(2004)
J Clin Invest
, vol.113
, pp. 561-568
-
-
Shimada, T.1
Kakitani, M.2
Yamazaki, Y.3
-
17
-
-
13544270218
-
An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia
-
Benet-Pages A, Orlik P, Strom TM et al. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. HumMol Genet 2005; 14: 385-390
-
(2005)
HumMol Genet
, vol.14
, pp. 385-390
-
-
Benet-Pages, A.1
Orlik, P.2
Strom, T.M.3
-
18
-
-
34250667000
-
Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice
-
Stubbs JR, Liu S, Tang W et al. Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol 2007; 18: 2116-2124
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 2116-2124
-
-
Stubbs, J.R.1
Liu, S.2
Tang, W.3
-
19
-
-
84888219981
-
Calcium regulates FGF-23 expression in bone
-
David V, Dai B, Martin A et al. Calcium regulates FGF-23 expression in bone. Endocrinology 2013; 154: 4469-4482
-
(2013)
Endocrinology
, vol.154
, pp. 4469-4482
-
-
David, V.1
Dai, B.2
Martin, A.3
-
20
-
-
33646367420
-
Fibroblast growth factor 23 is a counterregulatory phosphaturic hormone for Vitamin D
-
Liu S, Tang W, Zhou J et al. Fibroblast growth factor 23 is a counterregulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 2006; 17: 1305-1315
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 1305-1315
-
-
Liu, S.1
Tang, W.2
Zhou, J.3
-
21
-
-
84857067427
-
Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo
-
Lopez I, Rodriguez-Ortiz ME, Almaden Y et al. Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo. Kidney Int 2011; 80: 475-482
-
(2011)
Kidney Int
, vol.80
, pp. 475-482
-
-
Lopez, I.1
Rodriguez-Ortiz, M.E.2
Almaden, Y.3
-
22
-
-
84866366740
-
Update on fibroblast growth factor 23 in chronic kidney disease
-
Wolf M. Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int 2012; 82: 737-747
-
(2012)
Kidney Int
, vol.82
, pp. 737-747
-
-
Wolf, M.1
-
23
-
-
32444451549
-
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
-
Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 2006; 116: 288-296
-
(2006)
J Clin Invest
, vol.116
, pp. 288-296
-
-
Remuzzi, G.1
Benigni, A.2
Remuzzi, A.3
-
24
-
-
84555187565
-
Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease
-
Stubbs JR, He N, Idiculla A et al. Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease. J BoneMiner Res 2012; 27: 38-46
-
(2012)
J BoneMiner Res
, vol.27
, pp. 38-46
-
-
Stubbs, J.R.1
He, N.2
Idiculla, A.3
-
25
-
-
34548230927
-
Getting to the site of inflammation: The leukocyte adhesion cascade updated
-
Ley K, Laudanna C, Cybulsky MI et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007; 7: 678-689
-
(2007)
Nat Rev Immunol
, vol.7
, pp. 678-689
-
-
Ley, K.1
Laudanna, C.2
Cybulsky, M.I.3
-
26
-
-
81255188938
-
The neutrophil in vascular inflammation
-
Phillipson M, Kubes P. The neutrophil in vascular inflammation. Nat Med 2011; 17: 1381-1390
-
(2011)
Nat Med
, vol.17
, pp. 1381-1390
-
-
Phillipson, M.1
Kubes, P.2
-
27
-
-
0242368135
-
Arrest chemokines
-
Ley K. Arrest chemokines.Microcirculation 2003; 10: 289-295
-
(2003)
Microcirculation
, vol.10
, pp. 289-295
-
-
Ley, K.1
-
28
-
-
79957984039
-
Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease a crosssectional study of predialysis, dialysis and kidney-transplantation patients
-
Recio-Mayoral A, Banerjee D, Streather C et al. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease-A crosssectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 2011; 216: 446-451
-
(2011)
Atherosclerosis
, vol.216
, pp. 446-451
-
-
Recio-Mayoral, A.1
Banerjee, D.2
Streather, C.3
-
29
-
-
84923104493
-
Update on inflammation in chronic kidney disease
-
Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif 2015; 39: 84-92
-
(2015)
Blood Purif
, vol.39
, pp. 84-92
-
-
Akchurin, O.M.1
Kaskel, F.2
-
30
-
-
5444257487
-
Oxidative stress in uremia: Nature, mechanisms, and potential consequences
-
Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004; 24: 469-473
-
(2004)
Semin Nephrol
, vol.24
, pp. 469-473
-
-
Vaziri, N.D.1
-
31
-
-
84871731386
-
Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC
-
Gupta J, Mitra N, Kanetsky PA et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol 2012; 7: 1938-1946
-
(2012)
Clin J Am Soc Nephrol
, vol.7
, pp. 1938-1946
-
-
Gupta, J.1
Mitra, N.2
Kanetsky, P.A.3
-
34
-
-
84872893571
-
Preventing and treating inflammation: Role of dialysis access management
-
Nassar GM. Preventing and treating inflammation: role of dialysis access management. Semin Dial 2013; 26: 28-30
-
(2013)
Semin Dial
, vol.26
, pp. 28-30
-
-
Nassar, G.M.1
-
35
-
-
84896725954
-
Prevalence and severity of oral disease in adults with chronic kidney disease: A systematic review of observational studies
-
Ruospo M, Palmer SC, Craig JC et al. Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies. Nephrol Dial Transplant 2014; 29: 364-375
-
(2014)
Nephrol Dial Transplant
, vol.29
, pp. 364-375
-
-
Ruospo, M.1
Palmer, S.C.2
Craig, J.C.3
-
36
-
-
84935142799
-
Platelets in leucocyte recruitment and function
-
Rossaint J, Zarbock A. Platelets in leucocyte recruitment and function. Cardiovasc Res 2015; 107: 386-395
-
(2015)
Cardiovasc Res
, vol.107
, pp. 386-395
-
-
Rossaint, J.1
Zarbock, A.2
-
37
-
-
49249104701
-
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
-
Gutierrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592
-
(2008)
N Engl J Med
, vol.359
, pp. 584-592
-
-
Gutierrez, O.M.1
Mannstadt, M.2
Isakova, T.3
-
38
-
-
79958724181
-
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease
-
Isakova T, Xie H, Yang W et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 2011; 305: 2432-2439
-
(2011)
JAMA
, vol.305
, pp. 2432-2439
-
-
Isakova, T.1
Xie, H.2
Yang, W.3
-
39
-
-
84954426824
-
Low Vitamin D and high fibroblast growth factor 23 serum levels associate with infectious and cardiac deaths in the HEMO study
-
Chonchol M, Greene T, Zhang Y et al. Low vitamin D and high fibroblast growth factor 23 serum levels associate with infectious and cardiac deaths in the HEMO study. J Am SocNephrol 2016; 27: 227-237
-
(2016)
J Am SocNephrol
, vol.27
, pp. 227-237
-
-
Chonchol, M.1
Greene, T.2
Zhang, Y.3
-
40
-
-
84942884771
-
Cause of death in patients with reduced kidney function
-
Thompson S, James M, Wiebe N et al. Cause of death in patients with reduced kidney function. J AmSoc Nephrol 2015; 26: 2504-2511
-
(2015)
J AmSoc Nephrol
, vol.26
, pp. 2504-2511
-
-
Thompson, S.1
James, M.2
Wiebe, N.3
-
41
-
-
84863550146
-
FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality
-
Shalhoub V, Shatzen EM, Ward SC et al. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Invest 2012; 122: 2543-2553
-
(2012)
J Clin Invest
, vol.122
, pp. 2543-2553
-
-
Shalhoub, V.1
Shatzen, E.M.2
Ward, S.C.3
-
42
-
-
30944441131
-
Progression of kidney disease: Blocking leukocyte recruitment with chemokine receptor CCR1 antagonists
-
Anders HJ, Ninichuk V, Schlondorff D. Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. Kidney Int 2006; 69: 29-32
-
(2006)
Kidney Int
, vol.69
, pp. 29-32
-
-
Anders, H.J.1
Ninichuk, V.2
Schlondorff, D.3
-
43
-
-
0141618429
-
The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing
-
Anding K, Gross P, Rost JMet al. The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephrol Dial Transplant 2003; 18: 2067-2073
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 2067-2073
-
-
Anding, K.1
Gross, P.2
Rost, J.M.3
-
44
-
-
84857083564
-
Acute loss of renal function attenuates slow leukocyte rolling and transmigration by interfering with intracellular signaling
-
Rossaint J, Spelten O, Kassens N et al. Acute loss of renal function attenuates slow leukocyte rolling and transmigration by interfering with intracellular signaling. Kidney Int 2011; 80: 493-503
-
(2011)
Kidney Int
, vol.80
, pp. 493-503
-
-
Rossaint, J.1
Spelten, O.2
Kassens, N.3
-
45
-
-
84872841888
-
Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes
-
Bacchetta J, Sea JL, Chun RF et al. Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes. J Bone Miner Res 2013; 28: 46-55
-
(2013)
J Bone Miner Res
, vol.28
, pp. 46-55
-
-
Bacchetta, J.1
Sea, J.L.2
Chun, R.F.3
-
46
-
-
84869233330
-
Uremia suppresses immune signalinduced CYP27B1 expression in human monocytes
-
Viaene L, Evenepoel P, Meijers B et al. Uremia suppresses immune signalinduced CYP27B1 expression in human monocytes. Am J Nephrol 2012; 36: 497-508
-
(2012)
Am J Nephrol
, vol.36
, pp. 497-508
-
-
Viaene, L.1
Evenepoel, P.2
Meijers, B.3
-
47
-
-
0038375031
-
Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease
-
Stenvinkel P. Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease. J RenNutr 2003; 13: 144-148 | |
-
(2003)
J RenNutr
, vol.13
, pp. 144-148
-
-
Stenvinkel, P.1
-
48
-
-
81255188938
-
The neutrophil in vascular inflammation
-
Phillipson M, Kubes P. The neutrophil in vascular inflammation. Nat Med 2011; 17: 1381-1390
-
(2011)
Nat Med
, vol.17
, pp. 1381-1390
-
-
Phillipson, M.1
Kubes, P.2
-
49
-
-
0242368135
-
Arrest chemokines
-
Ley K. Arrest chemokines.Microcirculation 2003; 10: 289-295
-
(2003)
Microcirculation
, vol.10
, pp. 289-295
-
-
Ley, K.1
-
50
-
-
79957984039
-
Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease-a crosssectional study of predialysis, dialysis and kidney-transplantation patients
-
Recio-Mayoral A, Banerjee D, Streather C et al. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease-a crosssectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 2011; 216: 446-451
-
(2011)
Atherosclerosis
, vol.216
, pp. 446-451
-
-
Recio-Mayoral, A.1
Banerjee, D.2
Streather, C.3
-
51
-
-
84923104493
-
Update on inflammation in chronic kidney disease
-
Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif 2015; 39: 84-92
-
(2015)
Blood Purif
, vol.39
, pp. 84-92
-
-
Akchurin, O.M.1
Kaskel, F.2
-
52
-
-
5444257487
-
Oxidative stress in uremia: Nature, mechanisms, and potential consequences
-
Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004; 24: 469-473
-
(2004)
Semin Nephrol
, vol.24
, pp. 469-473
-
-
Vaziri, N.D.1
-
53
-
-
84871731386
-
Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC
-
Gupta J, Mitra N, Kanetsky PA et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol 2012; 7: 1938-1946
-
(2012)
Clin J Am Soc Nephrol
, vol.7
, pp. 1938-1946
-
-
Gupta, J.1
Mitra, N.2
Kanetsky, P.A.3
-
56
-
-
84872893571
-
Preventing and treating inflammation: Role of dialysis access management
-
Nassar GM. Preventing and treating inflammation: role of dialysis access management. Semin Dial 2013; 26: 28-30
-
(2013)
Semin Dial
, vol.26
, pp. 28-30
-
-
Nassar, G.M.1
-
57
-
-
84896725954
-
Prevalence and severity of oral disease in adults with chronic kidney disease: A systematic review of observational studies
-
Ruospo M, Palmer SC, Craig JC et al. Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies. Nephrol Dial Transplant 2014; 29: 364-375
-
(2014)
Nephrol Dial Transplant
, vol.29
, pp. 364-375
-
-
Ruospo, M.1
Palmer, S.C.2
Craig, J.C.3
-
58
-
-
84935142799
-
Platelets in leucocyte recruitment and function
-
Rossaint J, Zarbock A. Platelets in leucocyte recruitment and function. Cardiovasc Res 2015; 107: 386-395
-
(2015)
Cardiovasc Res
, vol.107
, pp. 386-395
-
-
Rossaint, J.1
Zarbock, A.2
-
59
-
-
49249104701
-
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
-
Gutierrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592
-
(2008)
N Engl J Med
, vol.359
, pp. 584-592
-
-
Gutierrez, O.M.1
Mannstadt, M.2
Isakova, T.3
-
60
-
-
79958724181
-
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease
-
Isakova T, Xie H, Yang W et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 2011; 305: 2432-2439
-
(2011)
JAMA
, vol.305
, pp. 2432-2439
-
-
Isakova, T.1
Xie, H.2
Yang, W.3
-
61
-
-
84954426824
-
Low Vitamin D and high fibroblast growth factor 23 serum levels associate with infectious and cardiac deaths in the HEMO study
-
Chonchol M, Greene T, Zhang Y et al. Low vitamin D and high fibroblast growth factor 23 serum levels associate with infectious and cardiac deaths in the HEMO study. J Am SocNephrol 2016; 27: 227-237
-
(2016)
J Am SocNephrol
, vol.27
, pp. 227-237
-
-
Chonchol, M.1
Greene, T.2
Zhang, Y.3
-
62
-
-
84942884771
-
Cause of death in patients with reduced kidney function
-
Thompson S, James M, Wiebe N et al. Cause of death in patients with reduced kidney function. J AmSoc Nephrol 2015; 26: 2504-2511
-
(2015)
J AmSoc Nephrol
, vol.26
, pp. 2504-2511
-
-
Thompson, S.1
James, M.2
Wiebe, N.3
-
63
-
-
84863550146
-
FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality
-
Shalhoub V, Shatzen EM, Ward SC et al. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Invest 2012; 122: 2543-2553
-
(2012)
J Clin Invest
, vol.122
, pp. 2543-2553
-
-
Shalhoub, V.1
Shatzen, E.M.2
Ward, S.C.3
-
64
-
-
30944441131
-
Progression of kidney disease: Blocking leukocyte recruitment with chemokine receptor CCR1 antagonists
-
Anders HJ, Ninichuk V, Schlondorff D. Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. Kidney Int 2006; 69: 29-32
-
(2006)
Kidney Int
, vol.69
, pp. 29-32
-
-
Anders, H.J.1
Ninichuk, V.2
Schlondorff, D.3
-
65
-
-
0141618429
-
The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing
-
Anding K, Gross P, Rost JMet al. The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephrol Dial Transplant 2003; 18: 2067-2073
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 2067-2073
-
-
Anding, K.1
Gross, P.2
Rost, J.M.3
-
66
-
-
84857083564
-
Acute loss of renal function attenuates slow leukocyte rolling and transmigration by interfering with intracellular signaling
-
Rossaint J, Spelten O, Kassens N et al. Acute loss of renal function attenuates slow leukocyte rolling and transmigration by interfering with intracellular signaling. Kidney Int 2011; 80: 493-503
-
(2011)
Kidney Int
, vol.80
, pp. 493-503
-
-
Rossaint, J.1
Spelten, O.2
Kassens, N.3
-
67
-
-
84872841888
-
Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes
-
Bacchetta J, Sea JL, Chun RF et al. Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes. J Bone Miner Res 2013; 28: 46-55
-
(2013)
J Bone Miner Res
, vol.28
, pp. 46-55
-
-
Bacchetta, J.1
Sea, J.L.2
Chun, R.F.3
-
68
-
-
84869233330
-
Uremia suppresses immune signalinduced CYP27B1 expression in human monocytes
-
Viaene L, Evenepoel P, Meijers B et al. Uremia suppresses immune signalinduced CYP27B1 expression in human monocytes. Am J Nephrol 2012; 36: 497-508
-
(2012)
Am J Nephrol
, vol.36
, pp. 497-508
-
-
Viaene, L.1
Evenepoel, P.2
Meijers, B.3
-
69
-
-
0038375031
-
Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease
-
Stenvinkel P. Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease. J RenNutr 2003; 13: 144-148
-
(2003)
J RenNutr
, vol.13
, pp. 144-148
-
-
Stenvinkel, P.1
-
70
-
-
81155152411
-
Markers of inflammation predict the longterm risk of developing chronic kidney disease: A population-based cohort study
-
Shankar A, Sun L, Klein BE et al.Markers of inflammation predict the longterm risk of developing chronic kidney disease: a population-based cohort study. Kidney Int 2011; 80: 1231-1238
-
(2011)
Kidney Int
, vol.80
, pp. 1231-1238
-
-
Shankar, A.1
Sun, L.2
Klein, B.E.3
-
71
-
-
84866127175
-
A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model
-
Dai B, David V, Martin A et al. A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model. PLoS One 2012; 7: e44161
-
(2012)
PLoS One
, vol.7
, pp. e44161
-
-
Dai, B.1
David, V.2
Martin, A.3
-
72
-
-
84957953317
-
Intact FGF23 and alpha-Klotho during acute inflammation/sepsis in CKD patients
-
Dounousi E, Torino C, Pizzini P et al. Intact FGF23 and alpha-Klotho during acute inflammation/sepsis in CKD patients. Eur J Clin Invest 2016; 46: 234-241
-
(2016)
Eur J Clin Invest
, vol.46
, pp. 234-241
-
-
Dounousi, E.1
Torino, C.2
Pizzini, P.3
-
73
-
-
84929707931
-
Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly
-
Holecki M, Chudek J, Owczarek A et al. Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly. Clin Endocrinol (Oxf) 2015; 82: 900-909
-
(2015)
Clin Endocrinol (Oxf)
, vol.82
, pp. 900-909
-
-
Holecki, M.1
Chudek, J.2
Owczarek, A.3
-
74
-
-
84945942478
-
Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy
-
Grabner A, Amaral AP, Schramm K et al. Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy. Cell Metab 2015; 22: 1020-1032
-
(2015)
Cell Metab
, vol.22
, pp. 1020-1032
-
-
Grabner, A.1
Amaral, A.P.2
Schramm, K.3
-
75
-
-
84908565099
-
Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli
-
Ito N,Wijenayaka AR, PrideauxM et al. Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli. Mol Cell Endocrinol 2015; 399: 208-218
-
(2015)
Mol Cell Endocrinol
, vol.399
, pp. 208-218
-
-
Ito, N.1
Wijenayaka, A.R.2
Prideaux, M.3
-
76
-
-
84969268627
-
Inflammation regulates fibroblast growth factor 23 production
-
Francis C, David V. Inflammation regulates fibroblast growth factor 23 production. Curr Opin Nephrol Hypertens 2016; 25: 325-332
-
(2016)
Curr Opin Nephrol Hypertens
, vol.25
, pp. 325-332
-
-
Francis, C.1
David, V.2
-
77
-
-
84946130633
-
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
-
David V, Martin A, Isakova T et al. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int 2016; 89: 135-146
-
(2016)
Kidney Int
, vol.89
, pp. 135-146
-
-
David, V.1
Martin, A.2
Isakova, T.3
-
78
-
-
84896733066
-
The iron cycle in chronic kidney disease (CKD): From genetics and experimental models to CKD patients
-
Zumbrennen-Bullough K, Babitt JL. The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients. Nephrol Dial Transplant 2014; 29: 263-273
-
(2014)
Nephrol Dial Transplant
, vol.29
, pp. 263-273
-
-
Zumbrennen-Bullough, K.1
Babitt, J.L.2
-
79
-
-
84881241741
-
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women
-
Wolf M, Koch TA, Bregman DB. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J BoneMiner Res 2013; 28: 1793-1803
-
(2013)
J BoneMiner Res
, vol.28
, pp. 1793-1803
-
-
Wolf, M.1
Koch, T.A.2
Bregman, D.B.3
-
80
-
-
84942848861
-
HIF hydroxylase pathways in cardiovascular physiology and medicine
-
Bishop T, Ratcliffe PJ. HIF hydroxylase pathways in cardiovascular physiology and medicine. Circ Res 2015; 117: 65-79
-
(2015)
Circ Res
, vol.117
, pp. 65-79
-
-
Bishop, T.1
Ratcliffe, P.J.2
-
81
-
-
84892698159
-
Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHRmice
-
Clinkenbeard EL, Farrow EG, Summers LJ et al. Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHRmice. J BoneMiner Res 2014; 29: 361-369
-
(2014)
J BoneMiner Res
, vol.29
, pp. 361-369
-
-
Clinkenbeard, E.L.1
Farrow, E.G.2
Summers, L.J.3
-
82
-
-
84857076647
-
Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery
-
Colgan SP, Eltzschig HK. Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery. Annu Rev Physiol 2012; 74: 153-175
-
(2012)
Annu Rev Physiol
, vol.74
, pp. 153-175
-
-
Colgan, S.P.1
Eltzschig, H.K.2
-
83
-
-
1642581653
-
Hypoxic gene activation by lipopolysaccharide in macrophages: Implication of hypoxia-inducible factor 1alpha
-
Blouin CC, Page EL, Soucy GM et al. Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha. Blood 2004; 103: 1124-1130
-
(2004)
Blood
, vol.103
, pp. 1124-1130
-
-
Blouin, C.C.1
Page, E.L.2
Soucy, G.M.3
-
84
-
-
44849100198
-
NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha
-
Rius J, Guma M, Schachtrup C et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008; 453: 807-811
-
(2008)
Nature
, vol.453
, pp. 807-811
-
-
Rius, J.1
Guma, M.2
Schachtrup, C.3
-
85
-
-
44449174536
-
Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia
-
Kuhlicke J, Frick JS, Morote-Garcia JC et al. Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS One 2007; 2: e1364
-
(2007)
PLoS One
, vol.2
, pp. e1364
-
-
Kuhlicke, J.1
Frick, J.S.2
Morote-Garcia, J.C.3
-
86
-
-
14844299760
-
Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: Impact on the bioactivation of proproteins
-
McMahon S, Grondin F, McDonald PP et al. Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteins. J Biol Chem2005; 280: 6561-6569
-
(2005)
J Biol Chem
, vol.280
, pp. 6561-6569
-
-
McMahon, S.1
Grondin, F.2
McDonald, P.P.3
-
89
-
-
77949837759
-
Tumor necrosis factor and interferon-gamma down-regulate Klotho in mice with colitis
-
1394e1-2
-
Thurston RD, Larmonier CB, Majewski PM et al. Tumor necrosis factor and interferon-gamma down-regulate Klotho in mice with colitis. Gastroenterology 2010; 138: 1384-1394, 1394.e1-2
-
(2010)
Gastroenterology
, vol.138
, pp. 1384-1394
-
-
Thurston, R.D.1
Larmonier, C.B.2
Majewski, P.M.3
|